Predictors for the Longevity of People with Diabetes in Buno Bedele and Illubabor Zones, South-west Ethiopia

References

• Nagaraj P, P D, Mansour RF, et al. Artificial flora algorithm-based feature selection with gradient boosted tree model for diabetes classification. Diabetes Metab Syndr Obes. 2021;14:2789. doi:10.2147/DMSO.S312787
   PubMed Web of Science ®Google Scholar
• Mukhtar Y, Galalain A, Yunusa U. A modern overview on diabetes mellitus: a chronic endocrine disorder. Eur J Biol. 2020;5(2):1–14. doi:10.47672/ejb.409
   Google Scholar
• Radzicka S, Pietryga M, Iciek R, Brązert J. et al. The role of visfatin in pathogenesis of gestational diabetes (GDM). Ginekol Pol. 2018;89(9):518–521. doi:10.5603/GP.a2018.0088
   PubMed Web of Science ®Google Scholar
• Chowdhury NH, Reaz MBI, Ali SHM, et al. Nomogram-based chronic kidney disease prediction model for type 1 diabetes mellitus patients using routine pathological data. J Pers Med. 2022;12(9):1507. doi:10.3390/jpm12091507
   PubMed Web of Science ®Google Scholar
• Chaudhury A, Duvoor C, Reddy Dendi VS, et al. Clinical review of antidiabetic drugs: implications for type 2 diabetes mellitus management. Front Endocrinol. 2017;8:6. doi:10.3389/fendo.2017.00006
   PubMed Web of Science ®Google Scholar
• Glovaci D, Fan W, Wong ND. Epidemiology of diabetes mellitus and cardiovascular disease. Curr Cardiol Rep. 2019;21:1–8.
   PubMed Web of Science ®Google Scholar
• Chawla A, Chawla R, Jaggi S. Microvascular and macrovascular complications in diabetes mellitus: distinct or continuum? Indian J Endocrinol Metab. 2016;20(4):546. doi:10.4103/2230-8210.183480
   PubMedGoogle Scholar
• Ighodaro O, Adeosun A. Vascular complications in diabetes mellitus. kidney. 2018;4:16–19.
   Google Scholar
• Reutrakul S, Van Cauter E. Interactions between sleep, circadian function, and glucose metabolism: implications for risk and severity of diabetes. Ann N Y Acad Sci. 2014;1311(1):151–173. doi:10.1111/nyas.12355
   PubMed Web of Science ®Google Scholar
• Beulens J, Rutters F, Rydén L, et al. Risk and management of pre-diabetes. Eur J Prev Cardiol. 2019;26(2_suppl):47–54. doi:10.1177/2047487319880041
   PubMed Web of Science ®Google Scholar
• Alam DS, Talukder SH, Chowdhury MAH, et al. Overweight and abdominal obesity as determinants of undiagnosed diabetes and pre-diabetes in Bangladesh. BMC Obes. 2016;3:1–12. doi:10.1186/s40608-016-0099-z
   PubMedGoogle Scholar
• Burch P, Blakeman T, Bower P, et al. Understanding the diagnosis of pre-diabetes in patients aged over 85 in English primary care: a qualitative study. BMC Fam Pract. 2019;20:1–10. doi:10.1186/s12875-019-0981-0
   PubMed Web of Science ®Google Scholar
• Mechanick JI, Farkouh ME, Newman JD, et al. Cardiometabolic-based chronic disease, addressing knowledge and clinical practice gaps: JACC state-of-the-art review. J Am Coll Cardiol. 2020;75(5):539–555. doi:10.1016/j.jacc.2019.11.046
   PubMed Web of Science ®Google Scholar
• Claas SA, Arnett DK. The role of healthy lifestyle in the primordial prevention of cardiovascular disease. Curr Cardiol Rep. 2016;18:1–8. doi:10.1007/s11886-016-0728-7
   PubMed Web of Science ®Google Scholar
• Ha J, Sherman A. Type 2 diabetes: one disease, many pathways. Am J Physiol Endocrinol Metab. 2020;319(2):E410–E426. doi:10.1152/ajpendo.00512.2019
   PubMed Web of Science ®Google Scholar
• Alsinani TS, Alanazi MD, Alkahtani MA, et al. Lifestyle modifications for hypertension management. Egypt J Hosp Med. 2018;70(12):2152–2156. doi:10.12816/0045044
   Google Scholar
• Pearson-Stuttard J, Buckley J, Cicek M, et al. The changing nature of mortality and morbidity in patients with diabetes. Endocrinol Metab Clin. 2021;50(3):357–368. doi:10.1016/j.ecl.2021.05.001
   Google Scholar
• Schwartz JI, Guwatudde D, Nugent R, et al. Looking at non-communicable diseases in Uganda through a local lens: an analysis using locally derived data. Global Health. 2014;10:1–9. doi:10.1186/s12992-014-0077-5
   PubMed Web of Science ®Google Scholar
• Alwin Robert A, Abdulaziz Al Dawish M, Braham R, et al. Type 2 diabetes mellitus in Saudi Arabia: major challenges and possible solutions. Curr Diabetes Rev. 2017;13(1):59–64. doi:10.2174/1573399812666160126142605
   PubMed Web of Science ®Google Scholar
• Kar SK, Oyetunji TP, Prakash AJ, et al. Mental health research in the lower-middle-income countries of Africa and Asia during the COVID-19 pandemic: a scoping review. Neurol Psychiatry Brain Res. 2020;38:54–64. doi:10.1016/j.npbr.2020.10.003
   PubMedGoogle Scholar
• Robinson S. Priorities for Health Promotion and Public Health: Explaining the Evidence for Disease Prevention and Health Promotion. Routledge; 2021.
   Google Scholar
• Chiwanga FS, Njelekela MA, Diamond MB, et al. Urban and rural prevalence of diabetes and pre-diabetes and risk factors associated with diabetes in Tanzania and Uganda. Glob Health Action. 2016;9(1):31440. doi:10.3402/gha.v9.31440
   PubMedGoogle Scholar
• Ali RAB, Hannoun Z, Harraqui K, et al. Profile of diabetes and cardiovascular risk factors in adults Anjouan Island (Comoros). Pan Afr Med J. 2019;2019:33.
   Google Scholar
• Molalign Takele G, Weharei MA, Kidanu HT, et al. Diabetes self-care practice and associated factors among type 2 diabetic patients in public hospitals of Tigray regional state, Ethiopia: a multicenter study. PLoS One. 2021;16(4):e0250462. doi:10.1371/journal.pone.0250462
   PubMed Web of Science ®Google Scholar
• Alebel A, Wondemagegn AT, Tesema C, et al. Prevalence of diabetes mellitus among tuberculosis patients in Sub-Saharan Africa: a systematic review and meta-analysis of observational studies. BMC Infect Dis. 2019;19(1):1–10. doi:10.1186/s12879-019-3892-8
   PubMedGoogle Scholar
• Khan MAB, Hashim MJ, King JK, et al. Epidemiology of type 2 diabetes–global burden of disease and forecasted trends. J Epidemiol Glob Health. 2020;10(1):107. doi:10.2991/jegh.k.191028.001
   PubMed Web of Science ®Google Scholar
• Gezae KE, Abebe HT, Gebretsadik LG. Incidence and predictors of LTFU among adults with TB/HIV co-infection in two governmental hospitals, Mekelle, Ethiopia, 2009–2016: survival model approach. BMC Infect Dis. 2019;19(1):1–9. doi:10.1186/s12879-019-3756-2
   PubMed Web of Science ®Google Scholar
• Group LAR. Effect of a long-term behavioural weight loss intervention on nephropathy in overweight or obese adults with type 2 diabetes: a secondary analysis of the Look AHEAD randomised clinical trial. Lancet Diabetes Endocrinol. 2014;2(10):801–809.
   PubMed Web of Science ®Google Scholar
• Moodley N, Ngxamngxa U, Turzyniecka MJ, et al. Historical perspectives in clinical pathology: a history of glucose measurement. J Clin Pathol. 2015;68(4):258–264. doi:10.1136/jclinpath-2014-202672
   PubMed Web of Science ®Google Scholar
• Prinja S, Gupta N, Verma R. Censoring in clinical trials: review of survival analysis techniques. Indian J Community Med. 2010;35(2):217. doi:10.4103/0970-0218.66859
   PubMedGoogle Scholar
• Aroda VR, Bain SC, Cariou B, et al. Efficacy and safety of once-weekly semaglutide versus once-daily insulin glargine as add-on to metformin (with or without sulfonylureas) in insulin-naive patients with type 2 diabetes (SUSTAIN 4): a randomised, open-label, parallel-group, multicentre, multinational, phase 3a trial. Lancet Diabetes Endocrinol. 2017;5(5):355–366.
   PubMed Web of Science ®Google Scholar
• Derks M, Bastiaannet E, van de Water W, et al. Impact of age on breast cancer mortality and competing causes of death at 10 years follow-up in the adjuvant TEAM trial. Eur J Cancer. 2018;99:1–8. doi:10.1016/j.ejca.2018.04.009
   PubMed Web of Science ®Google Scholar
• Macedo AF, Douglas I, Smeeth L, et al. Statins and the risk of type 2 diabetes mellitus: cohort study using the UK clinical practice research datalink. BMC Cardiovasc Disord. 2014;14:1–12. doi:10.1186/1471-2261-14-85
   PubMed Web of Science ®Google Scholar